Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,651 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
Vora P, Venugopal C, Salim SK, Tatari N, Bakhshinyan D, Singh M, Seyfrid M, Upreti D, Rentas S, Wong N, Williams R, Qazi MA, Chokshi C, Ding A, Subapanditha M, Savage N, Mahendram S, Ford E, Adile AA, McKenna D, McFarlane N, Huynh V, Wylie RG, Pan J, Bramson J, Hope K, Moffat J, Singh S. Vora P, et al. Among authors: singh m, singh s. Cell Stem Cell. 2020 Jun 4;26(6):832-844.e6. doi: 10.1016/j.stem.2020.04.008. Epub 2020 May 27. Cell Stem Cell. 2020. PMID: 32464096 Free article.
Brain metastasis-initiating cells: survival of the fittest.
Singh M, Manoranjan B, Mahendram S, McFarlane N, Venugopal C, Singh SK. Singh M, et al. Among authors: singh sk. Int J Mol Sci. 2014 May 22;15(5):9117-33. doi: 10.3390/ijms15059117. Int J Mol Sci. 2014. PMID: 24857921 Free PMC article. Review.
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C, Hallett R, Vora P, Manoranjan B, Mahendram S, Qazi MA, McFarlane N, Subapanditha M, Nolte SM, Singh M, Bakhshinyan D, Garg N, Vijayakumar T, Lach B, Provias JP, Reddy K, Murty NK, Doble BW, Bhatia M, Hassell JA, Singh SK. Venugopal C, et al. Among authors: singh m, singh sk. Clin Cancer Res. 2015 Dec 1;21(23):5324-37. doi: 10.1158/1078-0432.CCR-14-3147. Epub 2015 Jul 7. Clin Cancer Res. 2015. PMID: 26152745
STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation.
Singh M, Garg N, Venugopal C, Hallett R, Tokar T, McFarlane N, Mahendram S, Bakhshinyan D, Manoranjan B, Vora P, Qazi M, Arpin CC, Page B, Haftchenary S, Rosa DA, Lai PS, Gómez-Biagi RF, Ali AM, Lewis A, Geletu M, Murty NK, Hassell JA, Jurisica I, Gunning PT, Singh SK. Singh M, et al. Among authors: singh sk. Oncotarget. 2015 Sep 29;6(29):27461-77. doi: 10.18632/oncotarget.4742. Oncotarget. 2015. PMID: 26314961 Free PMC article.
RNAi screen identifies essential regulators of human brain metastasis-initiating cells.
Singh M, Venugopal C, Tokar T, Brown KR, McFarlane N, Bakhshinyan D, Vijayakumar T, Manoranjan B, Mahendram S, Vora P, Qazi M, Dhillon M, Tong A, Durrer K, Murty N, Hallet R, Hassell JA, Kaplan DR, Cutz JC, Jurisica I, Moffat J, Singh SK. Singh M, et al. Among authors: singh sk. Acta Neuropathol. 2017 Dec;134(6):923-940. doi: 10.1007/s00401-017-1757-z. Epub 2017 Aug 1. Acta Neuropathol. 2017. PMID: 28766011
EMT: Mechanisms and therapeutic implications.
Singh M, Yelle N, Venugopal C, Singh SK. Singh M, et al. Among authors: singh sk. Pharmacol Ther. 2018 Feb;182:80-94. doi: 10.1016/j.pharmthera.2017.08.009. Epub 2017 Aug 20. Pharmacol Ther. 2018. PMID: 28834698 Review.
Introduction to Cancer Stem Cells: Past, Present, and Future.
Bakhshinyan D, Adile AA, Qazi MA, Singh M, Kameda-Smith MM, Yelle N, Chokshi C, Venugopal C, Singh SK. Bakhshinyan D, et al. Among authors: singh m, singh sk. Methods Mol Biol. 2018;1692:1-16. doi: 10.1007/978-1-4939-7401-6_1. Methods Mol Biol. 2018. PMID: 28986882 Review.
Erratum to: Introduction to Cancer Stem Cells: Past, Present, and Future.
Bakhshinyan D, Adile AA, Qazi MA, Singh M, Kameda-Smith MM, Yelle N, Chokshi C, Venugopal C, Singh SK. Bakhshinyan D, et al. Among authors: singh m, singh sk. Methods Mol Biol. 2018;1692:E1. doi: 10.1007/978-1-4939-7401-6_19. Methods Mol Biol. 2018. PMID: 29185235 No abstract available.
Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.
Qazi MA, Vora P, Venugopal C, Adams J, Singh M, Hu A, Gorelik M, Subapanditha MK, Savage N, Yang J, Chokshi C, London M, Gont A, Bobrowski D, Grinshtein N, Brown KR, Murty NK, Nilvebrant J, Kaplan D, Moffat J, Sidhu S, Singh SK. Qazi MA, et al. Among authors: singh m, singh sk. Cancer Res. 2018 Sep 1;78(17):5023-5037. doi: 10.1158/0008-5472.CAN-18-0267. Epub 2018 Jun 26. Cancer Res. 2018. PMID: 29945963
12,651 results
You have reached the last available page of results. Please see the User Guide for more information.